TY - JOUR
T1 - Risk factors for hypotension in urgently intubated burn patients
AU - Dennis, Christopher J.
AU - Chung, Kevin K.
AU - Holland, Seth R.
AU - Yoon, Brian S.
AU - Milligan, Daun J.
AU - Nitzschke, Stephanie L.
AU - Maani, Christopher V.
AU - Hansen, Jacob J.
AU - Aden, James K.
AU - Renz, Evan M.
N1 - Funding Information:
This project was funded by the Clinical Trials Task Area of the United States Army Institute of Surgical Research .
PY - 2012/12
Y1 - 2012/12
N2 - Background: When urgently intubating patient in the burn intensive care unit (BICU), various induction agents, including propofol, are utilized that may induce hemodynamic instability. Methods: A retrospective review was performed of consecutive critically ill burn patients who underwent urgent endotracheal intubation in BICU. Basic burn-related demographic data, indication for intubation, and induction agents utilized were recorded. The primary outcomes of interest were clinically significant hypotension requiring immediate fluid resuscitation, initiation or escalation of vasopressors immediately after intubation. Secondary outcomes included ventilator days, stay length, and in-hospital mortality. Results: Between January 2003 and August 2010, we identified 279 urgent intubations in 204 patients. Of these, the criteria for presumed sepsis were met in 60% (n = 168) of the intubations. After intubation, 117 patients (42%) experienced clinically significant hypotension. Propofol (51%) was the most commonly utilized induction agent followed by etomidate (23%), ketamine (15%), and midazolam (11%). On multiple logistic regression, %TBSA (OR 1.016, 95% CI 1.004-1.027, p < 0.001) and presumed sepsis (OR 1.852, 95% CI 1.100-3.117, p = 0.02) were the only significant predictors of hypotension. None of the induction agents, including propofol, were significantly associated with hypotension in patients with or without presumed sepsis. Conclusions: In critically ill burn patients undergoing urgent endotracheal intubation, specific induction agents, including propofol, were not associated with clinically significant hypotension. Presumed sepsis and %TBSA were the most important risk factors.
AB - Background: When urgently intubating patient in the burn intensive care unit (BICU), various induction agents, including propofol, are utilized that may induce hemodynamic instability. Methods: A retrospective review was performed of consecutive critically ill burn patients who underwent urgent endotracheal intubation in BICU. Basic burn-related demographic data, indication for intubation, and induction agents utilized were recorded. The primary outcomes of interest were clinically significant hypotension requiring immediate fluid resuscitation, initiation or escalation of vasopressors immediately after intubation. Secondary outcomes included ventilator days, stay length, and in-hospital mortality. Results: Between January 2003 and August 2010, we identified 279 urgent intubations in 204 patients. Of these, the criteria for presumed sepsis were met in 60% (n = 168) of the intubations. After intubation, 117 patients (42%) experienced clinically significant hypotension. Propofol (51%) was the most commonly utilized induction agent followed by etomidate (23%), ketamine (15%), and midazolam (11%). On multiple logistic regression, %TBSA (OR 1.016, 95% CI 1.004-1.027, p < 0.001) and presumed sepsis (OR 1.852, 95% CI 1.100-3.117, p = 0.02) were the only significant predictors of hypotension. None of the induction agents, including propofol, were significantly associated with hypotension in patients with or without presumed sepsis. Conclusions: In critically ill burn patients undergoing urgent endotracheal intubation, specific induction agents, including propofol, were not associated with clinically significant hypotension. Presumed sepsis and %TBSA were the most important risk factors.
KW - Burns
KW - Critical care
KW - Induction
KW - Intubation
KW - Propofol
KW - Respiratory failure
UR - http://www.scopus.com/inward/record.url?scp=84868197214&partnerID=8YFLogxK
U2 - 10.1016/j.burns.2012.07.004
DO - 10.1016/j.burns.2012.07.004
M3 - Article
C2 - 22884966
AN - SCOPUS:84868197214
SN - 0305-4179
VL - 38
SP - 1181
EP - 1185
JO - Burns
JF - Burns
IS - 8
ER -